We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
88 hedge funds and large institutions have $107M invested in Sorrento Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
106% more capital invested
Capital invested by funds: $52.1M → $107M (+$55M)
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
25% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 16
4% more funds holding
Funds holding: 85 → 88 (+3)
34% less call options, than puts
Call options by funds: $2.27M | Put options by funds: $3.45M
Holders
88
Holders Change
+3
Holders Change %
+3.53%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
32
Reduced
20
Closed
16
Calls
$2.27M
Puts
$3.45M
Net Calls
-$1.18M
Net Calls Change
-$1.26M
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$9.54M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.15M |
| 3 |
BlackRock
New York
|
+$1.29M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.2M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$1.07M |
